Characteristics and Quality of Life in Gynecologic Cancer Patients with Chemotherapy-induced Peripheral Neuropathy

Characteristics and Quality of Life in Gynecologic Cancer Patients with Chemotherapy-induced Peripheral Neuropathy

PURPOSE: The purpose of this study was to identify chemotherapy induced peripheral neuropathy, quality of life of patients with gynecologic cancer. METHODS: This was a cross-sectional survey design. We collected 130 patients with gynecologic cancer. They complete a self reported questionnaire includ...

Full description

Bibliographic Details
Main Authors:	Ju Hyeon Jeong, Ju Hee Nho, Gi Suk Kim, Young Eun Lee, Sun Young Yu, Hyun Ju Lee, Yu Mi Sim, Young Sun Lee
Format:	Article
Language:	English
Published:	Korean Society of Women Health Nursing 2013-12-01
Series:	Korean Journal of Women Health Nursing
Subjects:	gynecologic neoplasm chemotherapy induced peripheral neuropathy quality of life
Online Access:	http://www.kjwhn.org/upload/pdf/kjwhn-19-201.pdf

Similar Items

Therapeutic Effects of Phytochemicals and Medicinal Herbs on Chemotherapy-Induced Peripheral Neuropathy
by: Gihyun Lee, et al.
Published: (2016-09-01)

Falls and Functional Impairments in Breast Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy
by: Hiroko Komatsu, et al.
Published: (2019-01-01)

Treatment strategies for chemotherapy-induced peripheral neuropathy: potential role of exercise
by: Karen Y. Wonders, et al.
Published: (2011-12-01)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
by: Alex Molassiotis, et al.
Published: (2019-06-01)

Chemotherapy-Induced Peripheral Neuropathy and Physiotherapy
by: Gro S. Haugen, et al.
Published: (2013-04-01)

Chemotherapy-induced-peripheral neuropathy, gait and fall risk in older adults following cancer treatment
by: Timothy F. Marshall, et al.
Published: (2017-12-01)

Characterization of Internal Validity Threats to Phase III Clinical Trials for Chemotherapy-Induced Peripheral Neuropathy Management: A Systematic Review
by: Deborah Lee, et al.
Published: (2019-01-01)

Physiotherapy management of chemotherapy-induced peripheral neuropathy in Pretoria, South Africa
by: Esther A. Niemand, et al.
Published: (2020-10-01)

Efficacy of Alpha Lipoic Acid Supplementation In Chemotherapy-Induced Peripheral Neuropathy
by: Mediarty Syahrir, et al.
Published: (2020-12-01)

Oxidative stress and nerve damage: Role in chemotherapy induced peripheral neuropathy
by: Aparna Areti, et al.
Published: (2014-01-01)

Flavonoids Alleviate Peripheral Neuropathy Induced by Anticancer Drugs
by: Manaal Siddiqui, et al.
Published: (2021-03-01)

Regulatable Transgene Expression for Prevention of Chemotherapy-Induced Peripheral Neuropathy
by: Daisuke Kawata, et al.
Published: (2017-09-01)

Chemotherapy induced peripheral neuropathic pain
by: Hue Jung Park
Published: (2014-07-01)

Integrated Medicine for Chemotherapy-Induced Peripheral Neuropathy
by: Chih-Hung Tsai, et al.
Published: (2021-08-01)

Relationships among Malnutrition, Depression and Quality of Life in Patients with Gynecologic Cancer receiving Chemotherapy
by: Ju Hee Nho, et al.
Published: (2014-06-01)

Whole-body vibration as a modality for the rehabilitation of peripheral neuropathies: implications for cancer survivors suffering from chemotherapy-induced peripheral neuropathy
by: Anna L.J. Verhulst, et al.
Published: (2015-02-01)

Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
by: Yang Li, et al.
Published: (2021-02-01)

The Role of Nucleotide Excision Repair in Cisplatin-Induced Peripheral Neuropathy: Mechanism, Prevention, and Treatment
by: Scarlett Acklin, et al.
Published: (2021-02-01)

Impact of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life in Patients with Advanced Lung Cancer Receiving Platinum-Based Chemotherapy
by: Hsing-Wei Hung, et al.
Published: (2021-05-01)

Assessment of Fall-Related Self-Efficacy: Characteristics that Influence the Perception of Patients with Chemotherapy-Induced Peripheral Neuropathy
by: Sena Yamamoto, et al.
Published: (2020-01-01)

Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy
by: Alex Molassiotis, et al.
Published: (2019-02-01)

Acupuncture Relieved Chemotherapy-Induced Peripheral Neuropathy in Patients with Breast Cancer: A Pilot Randomized Sham-Controlled Trial
by: Chien-Chen Huang, et al.
Published: (2021-08-01)

Drug Repositioning for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Mechanism- and Screening-Based Strategy
by: Shota Yamamoto, et al.
Published: (2021-01-01)

Ten weeks of home-based exercise attenuates symptoms of chemotherapy-induced peripheral neuropathy in breast cancer patients
by: Karen Y. Wonders, et al.
Published: (2013-09-01)

The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol
by: Chang eun Jang, et al.
Published: (2018-09-01)

Spinal Cord Stimulation as a Treatment Option for Refractory Chemotherapy-Induced Peripheral Neuropathy: Case Report
by: Arthur Lopes, et al.
Published: (2020-06-01)

Axonal Transport Impairment in Chemotherapy-Induced Peripheral Neuropathy
by: Gabriella Nicolini, et al.
Published: (2015-08-01)

Managing Chronic Kidney Disease and Chemotherapy-Induced Peripheral Neuropathy with Acupuncture and Herbal Medicine: A Case Study
by: Sunny-Kim Barden
Published: (2017-04-01)

Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
by: Hana Starobova, et al.
Published: (2017-05-01)

Small extracellular vesicles ameliorate peripheral neuropathy and enhance chemotherapy of oxaliplatin on ovarian cancer
by: Yi Zhang, et al.
Published: (2021-03-01)

The efficacy and safety of electro-acupuncture for alleviating chemotherapy-induced peripheral neuropathy in patients with coloreactal cancer: study protocol for a single-blinded, randomized sham-controlled trial
by: Kaiyin Chan, et al.
Published: (2020-01-01)

Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)
by: Jennifer M. Mongiovi, et al.
Published: (2018-11-01)

Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy
by: Giulia Fumagalli, et al.
Published: (2021-02-01)

Prevalence and predictors of peripheral neuropathy after breast cancer treatment
by: Mandana Kamgar, et al.
Published: (2021-10-01)

Chemotherapy-Induced Peripheral Neuropathy and Changes in Cytoskeleton
by: Alessio Malacrida, et al.
Published: (2019-05-01)

Modulation by Ozone Therapy of Oxidative Stress in Chemotherapy-Induced Peripheral Neuropathy: The Background for a Randomized Clinical Trial
by: Bernardino Clavo, et al.
Published: (2021-03-01)

Review of the Role of the Brain in Chemotherapy-Induced Peripheral Neuropathy
by: Maryam Omran, et al.
Published: (2021-06-01)

Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time
by: Mian Wang, et al.
Published: (2019-11-01)

Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial
by: Adams, A., et al.
Published: (2022)

New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy
by: Janet Schloss, et al.
Published: (2016-01-01)